Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a new study, neuroscientists have found that raised blood pressure and diabetes in mid-life alter brain structure to slow thinking speed and memory.

Three scientists looking at a computer screen in an open plan office
Dr Xin You Tai, DPhil student, Dr Michele Veldsman, Postdoctoral Research Scientist in Cognitive Neurology and Masud Husain, Professor of Neurology and Cognitive Neuroscience

Looking at results from 22,000 volunteers in the UK Biobank who underwent brain scanning, the scientists found that raised blood pressure and diabetes significantly impaired the brain’s cognitive functions, specifically the performance of thinking speed and short-term memory.

Masud Husain, Professor of Neurology and Cognitive Neuroscience at the Nuffield Department of Clinical Neurosciences and lead investigator of the study, said, ‘For blood pressure, every mm of pressure in your arteries counts – even in people who aren’t on any treatment. For people who are on treatment, systolic blood pressures above 140 mm were associated with lower cognitive performance. The higher the pressure, the worse it is.’

Monitoring and treating even modestly raised blood pressure might make a difference to the structure of the brain and speed of thinking in mid-life, while also offering potential to reduce the risks of developing dementia later in life.
- Professor Masud Husain

The study, published in Nature Communications, shows the effects of blood pressure were strongest in people aged 44-69. Whereas in people aged above 70, the level of pressure did not have such an impact on the brain’s cognitive function.

These effects appear to be mediated by alterations in brain structure that were detected using new MRI brain scanning analysis techniques. The brain changes occurred in people with high blood pressure and diabetes, who were otherwise healthy individuals.

Some researchers have previously shown that blood pressure and diabetes in mid-life can increase the risk of developing dementia later in life. The new findings of the Oxford group reveal that these factors can also have a direct impact on cognitive performance in mid-life.

Dr. Michele Veldsman, Postdoctoral Research Scientist in Cognitive Neurology at the Department of Experimental Psychology and co-author of the study, said, ‘The MRI scans show that raised blood pressure and glucose seem to alter both the grey matter and the white matter connections in the brain.’

Dr. Xin You Tai, collaborator and DPhil student at the Nuffield Department of Clinical Neurosciences, said, ‘These changes seem to have a direct impact on the speed of thinking and short-term memory.’

The findings have important implications for brain health and may help neuroscientists answer how we can keep our brains healthy and more resilient as we get older.

Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Two NDCN students join BNA Scholars Programme

The British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ophthalmology Conference in Kyiv

On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.

Ashmolean turns red for World Encephalitis Day

Our researchers are tackling the devastating brain condition encephalitis.

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.